PepGen
Biotechnology Research
321 Harrison Ave
74 employees
- Employees
- 74
- Contacts
- 4
- Emails
- 4
- Phones
- 1
PepGen Overview
- Headquarters
- 321 Harrison Ave
- Website
- pepgen.com
- Industry
- Biotechnology Research
- Employees
- 74
- Founded
- 2018
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About PepGen
Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders.
PepGen Contact Details
- People in AeroLeads
- 4
- With contact data
- 4
- Email contacts
- 4
- 100.0% coverage
- Phone contacts
- 1
- 25.0% coverage
PepGen Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Jim Dolan | 3,000+ Jobs Created - C-level Growth | Somerville, Massachusetts, United States |
Email
|
| Lisa Wyman | Life Sciences Executive - Technical | Boston, Massachusetts, United States |
Email
|
| Teresa Raimondi | Reading, Massachusetts, United States |
Email
|
|
| James Mcarthur | Chief Executive Officer at Pepgen | Boston, Massachusetts, United States |
Email
Phone
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Compare Similar Companies to PepGen
Biogen
Biotechnology Research
Vertex Pharmaceuticals
Biotechnology Research
Beam Therapeutics
Biotechnology Research
Intellia Therapeutics, Inc.
Biotechnology Research
Wave Life Sciences
Biotechnology Research
Verve Therapeutics
Biotechnology Research
Kymera Therapeutics
Biotechnology Research
Dyne Therapeutics
Biotechnology Research
Entrada Therapeutics
Biotechnology Research
PepGene
Biotechnology Research